Carl W. Langren - Net Worth and Insider Trading
Carl W. Langren Net Worth
The estimated net worth of Carl W. Langren is at least $33,598 dollars as of 2024-11-13. Carl W. Langren is the Principal Accounting Officer of Lumos Pharma Inc and owns about 7,706 shares of Lumos Pharma Inc (LUMO) stock worth over $33,598. Details can be seen in Carl W. Langren's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carl W. Langren has not made any transactions after 2017-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carl W. Langren
Carl W. Langren Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carl W. Langren owns 1 companies in total, including Lumos Pharma Inc (LUMO) .
Click here to see the complete history of Carl W. Langren’s form 4 insider trades.
Insider Ownership Summary of Carl W. Langren
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LUMO | Lumos Pharma Inc | 2017-11-21 | Principal Accounting Officer |
Carl W. Langren Latest Holdings Summary
Carl W. Langren currently owns a total of 1 stock. Carl W. Langren owns 7,706 shares of Lumos Pharma Inc (LUMO) as of November 21, 2017, with a value of $33,598.
Latest Holdings of Carl W. Langren
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LUMO | Lumos Pharma Inc | 2017-11-21 | 7,706 | 4.36 | 33,598 |
Holding Weightings of Carl W. Langren
Carl W. Langren Form 4 Trading Tracker
According to the SEC Form 4 filings, Carl W. Langren has made a total of 0 transactions in Lumos Pharma Inc (LUMO) over the past 5 years. The most-recent trade in Lumos Pharma Inc is the sale of 248 shares on November 21, 2017, which brought Carl W. Langren around $20,173.
Insider Trading History of Carl W. Langren
- 1
Carl W. Langren Trading Performance
Carl W. Langren Ownership Network
Ownership Network List of Carl W. Langren
Ownership Network Relation of Carl W. Langren
Carl W. Langren Owned Company Details
What does Lumos Pharma Inc do?
Who are the key executives at Lumos Pharma Inc?
Carl W. Langren is the Principal Accounting Officer of Lumos Pharma Inc. Other key executives at Lumos Pharma Inc include Chief Medical Officer David B Karpf , Chief Business Officer Aaron Schuchart , and 10 percent owner & other: Possible Member of 10% Group James E Flynn .
Lumos Pharma Inc (LUMO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lumos Pharma Inc Insider Transactions
Carl W. Langren Mailing Address
Above is the net worth, insider trading, and ownership report for Carl W. Langren. You might contact Carl W. Langren via mailing address: C/o Newlink Genetics Corporation, 2503 South Loop Drive, Ames Ia 50010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
